PT Prodia Widyahusada TbkPRWDF 69 EV-to-EBIT is 0.00 as of Jul. 07, 2026. GuruFocus rates PRWDF with a GF Score™ of 69/100. The stock has 2 warning signs investors should review. Among 107 Medical Diagnostics & Research companies, PT Prodia Widyahusada Tbk ranks better than 90.65% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
PT Prodia Widyahusada Tbk's Enterprise Value for the quarter that ended in Mar. 2026 was $0.00 Mil.
PT Prodia Widyahusada Tbk's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $16.93 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Prodia Widyahusada Tbk EV-to-EBIT Related Terms
PT Prodia Widyahusada Tbk EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, PT Prodia Widyahusada Tbk's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Prodia Widyahusada Tbk EV-to-EBIT vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, PT Prodia Widyahusada Tbk's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where PT Prodia Widyahusada Tbk's EV-to-EBIT falls into.
PT Prodia Widyahusada Tbk's current Enterprise Value is $0.00 Mil.
PT Prodia Widyahusada Tbk's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $16.93 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Prodia Widyahusada Tbk (PRWDF) has a EV-to-EBIT of 0.00 as of Jul. 07, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on PT Prodia Widyahusada Tbk and its competitors. Over the past decade, PT Prodia Widyahusada Tbk's EV-to-EBIT has ranged from 4.17 to 123.66. According to the industry distribution chart, PT Prodia Widyahusada Tbk ranks #10 out of 107 companies in the Medical Diagnostics & Research industry, placing it in the top 9.3%.
Is PT Prodia Widyahusada Tbk's EV-to-EBIT too high?
PT Prodia Widyahusada Tbk's current EV-to-EBIT is 0.00. Over the past 10 years, this metric has ranged from a low of 4.17 to a high of 123.66. Based on the distribution chart, PT Prodia Widyahusada Tbk ranks #10 out of 107 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, PT Prodia Widyahusada Tbk has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does PT Prodia Widyahusada Tbk's EV-to-EBIT compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, PT Prodia Widyahusada Tbk ranks #10 out of 107 companies for EV-to-EBIT. This places PT Prodia Widyahusada Tbk in the top 9% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 22.51. Historically, PT Prodia Widyahusada Tbk's own EV-to-EBIT has ranged from 4.17 to 123.66 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Diagnostics & Research company?
The median EV-to-EBIT among Medical Diagnostics & Research companies is 22.51, based on 107 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on PT Prodia Widyahusada Tbk and its competitors. For the Medical Diagnostics & Research industry, the median EV-to-EBIT is 22.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Prodia Widyahusada Tbk's current EV-to-EBIT is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Prodia Widyahusada Tbk stock overvalued right now?
PT Prodia Widyahusada Tbk (PRWDF) has a current EV-to-EBIT of 0.00. The current EV-to-EBIT is 0.00. PT Prodia Widyahusada Tbk's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For PT Prodia Widyahusada Tbk (PRWDF), the current EV-to-EBIT is 0.00 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT Prodia Widyahusada Tbk provides health care testing services. The company provides analytic and diagnostic services for the medical professionals. It is engaged in health laboratories by conducting business activities such as setting up clinics, health laboratories, management of hospitals, and health checkup services. Its operating segments are Central: Jakarta; Sumatera: Sumatera, Kepulauan Riau; Greater Jakarta: Jakarta, Bogor, Depok, Tangerang, Bekasi, Lampung, Pangkal Pinang; West Java; Central Java; East Java, Bali, Nusa Tenggara; Kalimantan Sulampua: Kalimantan, Sulawesi, Ambon, Papua.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PRWDF has been successfully added to your 